GlassScriptPhysician profile
John Drew Prosser
NPI 1942462627
$2,316.52
in general payments reported to CMS, 2019-2025
17 companies · $1,029 in 2025
The $1,029 reported for 2025 was more than what 85% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $33.84 · 2021: $174 · 2022: $240 · 2023: $325 · 2024: $324 · 2025: $1,029.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,440 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,440.39 |
| Travel and Lodging | $237.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $674.20 | 2021-2025 | Stealthstation S8 Platform, Nim Vital, Plasmablade(Tm) |
| Inspire Medical Systems, INC. | $382.21 | 2025 | Inspire |
| Integra Lifesciences Corporation | $293.28 | 2019-2023 | Integra, Integra Duo, Instruments-Orthopedic |
| Depuy Synthes Sales INC. | $145.99 | 2024-2025 | Trumatch, Matrixcombo |
| Ambu INC. | $135.34 | 2021 | |
| Acera Surgical, INC. | $129.56 | 2023 | Restrata Wound Matrix |
| Regeneron Healthcare Solutions, INC. | $114.89 | 2020-2025 | Libtayo, Dupixent |
| Solventum Corporation | $114.12 | 2024 | V.A.C.Instill, V.A.C. Granufoam |
| Smith+Nephew, INC. | $83.50 | 2025 | Tula, Halo |
| Medtronic USA, INC. | $79.71 | 2019 | |
| Genzyme Corporation | $34.56 | 2025 | |
| Preceptis Medical, INC. | $33.34 | 2023-2025 | Hummingbird Tympanostomy Tube System |
| Cumberland Pharmaceuticals, INC. | $23.87 | 2025 | Caldolor |
| Karl Storz Endoscopy-America | $21.49 | 2019 | |
| Pentax of America, INC. | $18.61 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.04 | 2023 | Nucala |
| Axogen | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Prosser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.